Tenascin-X deficiency is associated with Ehlers-Danlos syndrome
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The tenascins are a family of large extracellular matrix proteins with at least three members: tenascin-X (TNX), tenascin-C (TNC, or cytotactin) and tenascin-R (TN-R, or restrictin). Although the tenascins have been implicated in a number of important cellular processes, no function has been clearly established for any tenascin. We describe a new contiguous-gene syndrome, involving the CYP21B and TNX genes, that results in 21-hydroxylase deficiency and a connective-tissue disorder consisting of skin and joint hyperextensibility, vascular fragility and poor wound healing. The connective tissue findings are typical of the Ehlers-Danlos syndrome (EDS). The abundant expression of TNX in connective tissues is consistent with a role in EDS, and our patient's skin fibroblasts do not synthesize TNX protein in vitro or in vivo. His paternal allele carries a novel deletion arising from recombination between TNX and its partial duplicate gene, XA, which precludes TNX synthesis. Absence of TNX mRNA and protein in the proband, mapping of the TNX gene and HLA typing of this family suggest recessive inheritance of TNX deficiency and connective-tissue disease. Although the precise role of TNX in the pathogenesis of EDS is uncertain, this patient's findings suggest a unique and essential role for TNX in connective-tissue structure and function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This rare chimera is characterized by a 120-bp deletion in exon 35 of TNXB and results in TNXB haploinsufficiency and disrupted TGF-β signaling; when found in the homozygous state, it leads to a contiguous gene syndrome consisting of CAH and Ehlers-Danlos syndrome (EDS) [7, 31].”
From Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene (2023) · cites this paper as [31]
In the citing paper
“This rare chimera is characterized by a 120-bp deletion in exon 35 of TNXB and results in TNXB haploinsufficiency and disrupted TGF-β signaling; when found in the homozygous state, it leads to a contiguous gene syndrome consisting of CAH and Ehlers-Danlos syndrome (EDS) [7, 31].”
From Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene (2023) · cites this paper as [31]
In the citing paper
“It has been reported that heterozygous TNXB mutations may be associated with the mild joint hypermobility form of EDS [1, 15] and that up to 10% of classic SW-CAH patients harboring in compound heterozygosity a TNXB/CYP21A2 genotype tend to demonstrate an extended phenotype termed CAH-X syndrome [1, 31, 32] (Fig. 2).”
From Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene (2023) · cites this paper as [31]
In the citing paper
“This rare chimera is characterized by a 120-bp deletion in exon 35 of TNXB and results in TNXB haploinsufficiency and disrupted TGF-β signaling; when found in the homozygous state, it leads to a contiguous gene syndrome consisting of CAH and Ehlers-Danlos syndrome (EDS) [7, 31].”
From Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene (2023) · cites this paper as [31]
In the citing paper
“Skin biopsy of this patient showed small collagen fibers of normal shape and a complete absence of tenascin XB (TNX).Cultured dermal fibroblasts also lacked TNX.”
From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Burch et al. [1997]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Chiquet-Ehrismann, R., Mackie, E. J., Pearson, C. A., & Sakakura, T. (1986) · Cell · doi:10.1016/0092-8674(86)90374-0 · Cited by 992
Mice develop normally without tenascin.
Saga, Y., Yagi, T., Ikawa, Y., Sakakura, T., & Aizawa, S. (1992) · Genes & Development · doi:10.1101/gad.6.10.1821 · Cited by 582
A Heritable Disorder of Connective Tissue: Hydroxylysine-Deficient Collagen Disease
Pinnell, S. R., Krane, S. M., Kenzora, J. E., & Glimcher, M. J. (1972) · New England Journal of Medicine · doi:10.1056/nejm197205112861901 · Cited by 414
Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions
Erickson, H. P. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90037-q · Cited by 399
Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B
Bristow, J., Tee, M., Gitelman, S., Mellon, S., & Miller, W. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.265 · Cited by 302
Self-citationA six-armed oligomer isolated from cell surface fibronectin preparations
Erickson, H. P., & Inglesias, J. L. (1984) · Nature · doi:10.1038/311267a0 · Cited by 274
Skin wounds and severed nerves heal normally in mice lacking tenascin-C.
Forsberg, E., Hirsch, E., Fröhlich, L., Meyer, M., Ekblom, P., Aszodi, A., Werner, S., & Fässler, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6594 · Cited by 235
Characterization of frequent deletions causing steroid 21-hydroxylase deficiency
White, P. C., Vitek, A., Dupont, B., & New, M. I. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4436 · Cited by 229
Fuss, B., Wintergerst, E. S., Bartsch, U., & Schachner, M. (1993) · The Journal of cell biology · doi:10.1083/jcb.120.5.1237 · Cited by 177
Jones, F. S., Burgoon, M. P., Hoffman, S., Crossin, K. L., Cunningham, B. A., & Edelman, G. M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2186 · Cited by 176
Cited by
Items 101–200 of 366
Egging, D., van Vlijmen-Willems, I., van Tongeren, T., Schalkwijk, J., & Peeters, A. (2007) · Connective Tissue Research · doi:10.1080/03008200601166160 · Cited by 63
“Fragile skin is a hallmark of EDS and is observed in TNX-deficient patients [6, 7, 10].”
BackgroundResultInfluentialThe molecular genetics of the Ehlers-Danlos syndrome
Burrows (1999) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.1999.00427.x · Cited by 72
Tenascin-X, Congenital Adrenal Hyperplasia, and the CAH-X Syndrome
Miller, W. L., & Merke, D. P. (2018) · Hormone Research in Paediatrics · doi:10.1159/000481911 · Cited by 61
Self-citationComprehensive Mutation Analysis of the CYP21A2 Gene
Xu, Z., Chen, W., Merke, D. P., & McDonnell, N. B. (2013) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.06.001 · Cited by 62
Molecular and developmental mechanisms of congenital heart valve disease
Lincoln, J., & Yutzey, K. E. (2011) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20799 · Cited by 66
“, 2007) TENASCIN Ehlers–Danlos syndrome MVP Tenascin-X Viable and fertile (Burch et al., 1997; Bristow et al., 2005) TGFb Receptor-1 (TGFbR1) Loeys–Dietz syndrome MVP (Dietz et al.”
BackgroundDeficiency of tenascin-X causes a decrease in the level of expression of type VI collagen
Minamitani, T., Ariga, H., & Matsumoto, K. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.03.002 · Cited by 71
Demirdas, S., Dulfer, E., Robert, L., Kempers, M., van Beek, D., Micha, D., van Engelen, B. G., Hamel, B., Schalkwijk, J., Loeys, B., et al. (2017) · Clinical Genetics · doi:10.1111/cge.12853 · Cited by 60
“In 1997, the TNX-deficient type was first reported in a 26-year-old male patient with congenital adrenal hyperplasia due to 21-hydroxylase deficiency as well as hyperextensible skin, hypermobile joints, easy bruising, and poor wound healing (2).”
BackgroundGhali, N., Sobey, G. J., & Burrows, N. (2019) · BMJ · doi:10.1136/bmj.l4966 · Cited by 68
Baronio, F., Ortolano, R., Menabò, S., Cassio, A., Baldazzi, L., Natale, V. D., Tonti, G., Vestrucci, B., & Balsamo, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184605 · Cited by 60
“The first, which was described in 1997 [76] and later termed CAH-X CH-1, has TNXB exons 35–44 replaced with TNXA.”
BackgroundZweers, M., Dean, W., Van Kuppevelt, T., Bristow, J., & Schalkwijk, J. (2005) · Clinical Genetics · doi:10.1111/j.1399-0004.2005.00401.x · Cited by 58
“However, that EDS is not solely a disease of the collagens became clear by the identification of a clinically distinct, recessive type of EDS caused by deficiency of tenascin-X (TNX) (7, 8).”
BackgroundSelf-citationBiological Variation of N-Terminal Pro-Brain Natriuretic Peptide in Healthy Individuals
Melzi d’Eril, G., Tagnochetti, T., Nauti, A., Klersy, C., Papalia, A., Vadacca, G., Moratti, R., & Merlini, G. (2003) · Clinical Chemistry · doi:10.1373/49.9.1554 · Cited by 59
The Roles of Tenascins in Cardiovascular, Inflammatory, and Heritable Connective Tissue Diseases
Matsumoto, K., & Aoki, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.609752 · Cited by 64
Heritable Collagen Disorders: The Paradigm of the Ehlers—Danlos Syndrome
Byers, P. H., & Murray, M. L. (2012) · Journal of Investigative Dermatology · doi:10.1038/skinbio.2012.3 · Cited by 63
“The elegant studies by Burch et al. (1997) of a child with 21-hydroxylase deficiency and a form of EDS led to identification of a new gene, the loss of function of which explained the connective tissue manifestations.”
BackgroundTenascins in fibrotic disorders—from bench to bedside
Kasprzycka, M., Hammarström, C., & Haraldsen, G. (2015) · Cell Adhesion & Migration · doi:10.4161/19336918.2014.994901 · Cited by 56
“Tenascins and collagen synthesis A crucial role for tenascin X in collagen biology is suggested by the fact that its deficiency is associated with Ehlers-Danlos syndrome in humans.(29) Major clinical symptoms consist of skin hyperextensibility and joint laxity, while ultrastructural analyses reveal abnormalities in co…”
BackgroundKoppens, P. F. J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.21.2581 · Cited by 57
“A homozygous defect of TNXB causes type II Ehlers–Danlos syndrome, a connective-tissue disease (33,34).”
BackgroundWijesuriya, S. D., Zhang, G., Dardis, A., & Miller, W. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.38097 · Cited by 54
Self-citationCell adhesion to tenascin‐X: Mapping of cell adhesion sites and identification of integrin receptors
Elefteriou, F., Exposito, J., Garrone, R., & Lethias, C. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00563.x · Cited by 54
Ikuta, T., Sogawa, N., Ariga, H., Ikemura, T., & Matsumoto, K. (1998) · Gene · doi:10.1016/s0378-1119(98)00355-2 · Cited by 60
Lévy, P., Ripoche, H., Laurendeau, I., Lazar, V., Ortonne, N., Parfait, B., Leroy, K., Wechsler, J., Salmon, I., Wolkenstein, P., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0182 · Cited by 53
Joint hypermobility as a distinctive feature in the differential diagnosis of myopathies
Voermans, N. C., Bönnemann, C. G., Hamel, B. C. J., Jungbluth, H., & van Engelen, B. G. M. (2009) · Journal of Neurology · doi:10.1007/s00415-009-0105-1 · Cited by 56
“Various extracellular matrix molecules are involved in the pathophysiology of the various EDS types, although the major genetic causation of the hypermobile type in particular awaits clarification: type I and type V collagen (classical type); collagen III (vascular type); TNX (TNX-deficient type), and lysyl hydroxylas…”
SMA-MAP: A Plasma Protein Panel for Spinal Muscular Atrophy
Kobayashi, D. T., Shi, J., Stephen, L. L., Ballard, K., Dewey, R., Mapes, J. P., Chung, B., McCarthy, K. D., Swoboda, K. J., Crawford, T. O., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060113 · Cited by 57
Cytogenetics and Molecular Genetics of Myxoid Soft-Tissue Sarcomas
Nishio, J., Iwasaki, H., Nabeshima, K., & Naito, M. (2011) · Genetics Research International · doi:10.4061/2011/497148 · Cited by 58
“TNXB is thought to function in matrix maturation during wound healing, and its deficiency is associated with the connective tissue disorder Ehlers-Danlos syndrome [107].”
BackgroundPCR-based detection of the CYP21 deletion and TNXA/TNXB hybrid in the RCCX module
Lee, H.-H., Lee, Y., & Lin, C.-Y. (2004) · Genomics · doi:10.1016/j.ygeno.2003.11.006 · Cited by 52
The Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
Self-citationExpression of tenascin-C and its isoforms in the breast
Guttery, D. S., Shaw, J., Lloyd, K., Pringle, J. H., & Walker, R. A. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9249-9 · Cited by 57
“Other members of the TN family include tenascin-R (TNR or restrictin), which is restricted to the developing and adult nervous system [7, 8]; tenascin-W (TNW) [9], which is found in the ECM of bone, muscle and kidney [10] (also found recently in malignant mammary tumours [10] and postulated to be a marker of activated…”
BackgroundVoermans, N. C., Jenniskens, G. J., Hamel, B. C., Schalkwijk, J., Guicheney, P., & van Engelen, B. G. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31899 · Cited by 49
“Visual inspection revealed absence of TNX within muscle ECM [Burch et al., 1997; Voermans et al., 2007].”
BackgroundInfluentialThe human and mouse MHC class III region: a parade of 21 genes at the centromeric segment
Yu, C. Y., Yang, Z., Blanchong, C. A., & Miller, W. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01664-9 · Cited by 62
Self-citationConcolino, P., Mello, E., Zuppi, C., & Capoluongo, E. (2010) · cclm · doi:10.1515/cclm.2010.239 · Cited by 48
Matricellular Proteins in the Trabecular Meshwork: Review and Update
Chatterjee, A., Villarreal, G., & Rhee, D. J. (2014) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2014.0013 · Cited by 50
Tenascin C protects aorta from acute dissection in mice
Kimura, T., Shiraishi, K., Furusho, A., Ito, S., Hirakata, S., Nishida, N., Yoshimura, K., Imanaka‐Yoshida, K., Yoshida, T., Ikeda, Y., et al. (2014) · Scientific Reports · doi:10.1038/srep04051 · Cited by 48
Saxena, K., Kitzmiller, K. J., Wu, Y. L., Zhou, B., Esack, N., Hiremath, L., Chung, E. K., Yang, Y., & Yu, C. Y. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2008.11.018 · Cited by 47
Tenascin-X increases the stiffness of collagen gels without affecting fibrillogenesis
Margaron, Y., Bostan, L. E., Exposito, J., Malbouyres, M., Trunfio-Sfarghiu, A.-M., Berthier, Y., & Lethias, C. (2010) · Biophysical Chemistry · doi:10.1016/j.bpc.2009.12.011 · Cited by 57
“Indeed, TNX deficiency leads to the appearance of an Ehlers-Danlos Syndrome in huma ns [2].”
BackgroundRegulation of tenascin expression in bone
Morgan, J. M., Wong, A., Yellowley, C. E., & Genetos, D. C. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23265 · Cited by 50
“Its deletion is implicated in the connective tissue disorder Ehlers–Danlos syndrome [Burch et al., 1997].”
BackgroundLatent TGF-β Activation Is a Hallmark of the Tenascin Family
Aubert, A., Mercier‐Gouy, P., Aguero, S., Berthier, L., Liot, S., Prigent, L., Alcaraz, L. B., Verrier, B., Terreux, R., Moali, C., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.613438 · Cited by 47
“Human Embryonic Kidney (HEK)-293 cells expressing Epstein-Barr Nuclear Antigen 1 (EBNA1) were purchased from Invitrogen and maintained in the same complete medium in the presence of 250 mg/mL of G418 (Geneticin, PAA) as recommended by the manufacturer.”
BackgroundGötte, M., & Kresse, H. (2005) · Biochemical Genetics · doi:10.1007/s10528-005-1068-2 · Cited by 50
“Since patients deficient in tenascin-X develop additional defects associated with Ehlers-Danlos syndrome, such as skin and joint hyperextensibility and poor wound healing, a role for decorin glycosaminoglycan–tenascin-X interactions for the integrity of the extracellular matrix could also be envisaged in the galactosy…”
BackgroundInfluentialGenomic interval engineering of mice identifies a novel modulator of triglyceride production
Zhu, Y., Jong, M. C., Frazer, K. A., Gong, E. L., Krauss, R. M., Cheng, J., Boffelli, D., & Rubin, E. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1137 · Cited by 45
Petersen, J. W., & Douglas, J. Y. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.06.005 · Cited by 44
“One of the earliest studies of TNX deficiency linked this deficiency with the skin and joint hyperextensibility and connective tissue findings typical of EDS-HT [21].”
BackgroundThe extracellular matrix glycoprotein tenascin‐X regulates peripheral sensory and motor neurones
Aktar, R., Peiris, M., Fikree, A., Cibert‐Goton, V., Walmsley, M., Tough, I. R., Watanabe, P., Araujo, E. J. A., Mohammed, S. D., Delalande, J., et al. (2018) · The Journal of Physiology · doi:10.1113/jp276300 · Cited by 43
“Monogenic TNX deficiency causes hypermobility of skin including tissue fragility and musculoskeletal pain, a phenotype similar to hypermobile Ehlers-Danlos syndrome (hEDS) (Burch et al. 1997; Hakim & Grahame, 2003).”
BackgroundAdrenal cortex and its disorders
Miller, W. L., & Flück, C. E. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00022-6 · Cited by 60
Self-citationHomozygous Gly530Ser substitution in COL5A1 causes mild classical Ehlers‐Danlos syndrome
Giunta, C., Nuytinck, L., Raghunath, M., Haußer, I., Paepe, A. D., & Steinmann, B. U. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10373 · Cited by 43
“A clinically distinct recessive form of classical EDS caused by deficiency of tenascin-X (TNX) has also been described [Burch et al., 1997; Schalkwijk et al., 2001].”
BackgroundChimeric CYP21P/CYP21 and TNXA/TNXB genes in the RCCX module
Lee, H.-H. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.09.009 · Cited by 41
Compound heterozygous mutations of the TNXB gene cause primary myopathy
Pénisson-Besnier, I., Allamand, V., Beurrier, P., Martin, L., Schalkwijk, J., van Vlijmen‐Willems, I. M. J. J., Gartioux, C., Malfait, F., Syx, D., Macchi, L., et al. (2013) · Neuromuscular Disorders · doi:10.1016/j.nmd.2013.04.009 · Cited by 48
“An autosomal recessive form of EDS caused by TNX deficiency was originally described in one patient [5], and subsequently in seven additional individuals [6,7].”
Background21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia
Nimkarn, S., Gangishetti, P. K., Yau, M., & New, M. I. (2016) · Cited by 49
Titin-based stiffening of muscle fibers in Ehlers-Danlos Syndrome
Ottenheijm, C. A. C., Voermans, N. C., Hudson, B. D., Irving, T., Stienen, G. J. M., van Engelen, B. G., & Granzier, H. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01166.2011 · Cited by 40
Geffrotin, C., Horák, V., Créchet, F., Tricaud, Y., Lethias, C., Vincent-Naulleau, S. S., & Vielh, P. R. (2000) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(00)00158-6 · Cited by 44
Brounts, S. H., Rashmir‐Raven, A. M., & Black, S. S. (2001) · Veterinary Dermatology · doi:10.1046/j.0959-4493.2001.00256.x · Cited by 40
Androgen-dependent hereditary mouse keratoconus: linkage to an MHC region.
Tachibana, M., Adachi, W., Kinoshita, S., Kobayashi, Y., Honma, Y., Hiai, H., & Matsushima, Y. (2002) · PubMed · Cited by 40
Potential biomarkers of the mature intervertebral disc identified at the single cell level
Li, K., Kapper, D., Youngs, B., Kocsis, V., Mondal, S., Kraus, P., & Lufkin, T. (2018) · Journal of Anatomy · doi:10.1111/joa.12904 · Cited by 39
“Tenascin XB Tnxb Glycoprotein with anti-adhesive properties Mutations associated with Ehlers Danlos Syndrome Chiquet-Ehrismann & Tucker (2011), Burch et al. (1997), Mao et al.”
BackgroundGenes and Pseudogenes: Complexity of the RCCX Locus and Disease
Carrozza, C., Foca, L., De Paolis, E., & Concolino, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.709758 · Cited by 37
Inflammatory Regulation of Valvular Remodeling: The Good(?), the Bad, and the Ugly
Mahler, G. J., & Butcher, J. T. (2011) · International Journal of Inflammation · doi:10.4061/2011/721419 · Cited by 52
Latijnhouwers, M., Pfundt, R., Jongh, G. J. D., & Schalkwijk, J. (1998) · Matrix Biology · doi:10.1016/s0945-053x(98)90083-x · Cited by 38
Tenascin-X deficiency and Ehlers-Danlos syndrome: a case report and review of the literature
O’Connell, M., Burrows, N. P., Van Vlijmen-Willems, M. J. J., Clark, S. M., & Schalkwijk, J. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09949.x · Cited by 38
Reduced quantitative muscle function in tenascin-X deficient Ehlers-Danlos patients
Voermans, N. C., Altenburg, T. M., Hamel, B. C., de Haan, A., & van Engelen, B. G. (2007) · Neuromuscular Disorders · doi:10.1016/j.nmd.2007.04.004 · Cited by 36
“A clinically distinct, recessive form results from tenascin-X (TNX) deficiency [2,3].”
BackgroundMethodMizuno, K., Boudko, S., Engel, J., & Bächinger, H. P. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.462002 · Cited by 35
“Genetic studies have shown that the genes of types I, III, and V collagens (2), lysylhydroxylase 1 (coded by PLOD1 gene) (3), procollagen-N-proteinase (coded by ADAMTS2 gene) (4), FKBP22 (coded by FKBP14 gene) (5), and tenascin X (coded by TNXB gene) (6) cause EDS.”
BackgroundAlabi, B. R., LaRanger, R., & Shay, J. W. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.09.033 · Cited by 34
Matsumoto, K., Minamitani, T., Orba, Y., Sato, M., Sawa, H., & Ariga, H. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.03.041 · Cited by 38
Fikree, A., Aktar, R., Morris, J. K., Grahame, R., Knowles, C. H., & Aziz, Q. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.12942 · Cited by 33
Matricellular proteins in cutaneous wound healing
Cárdenas‐León, C. G., Mäemets‐Allas, K., Klaas, M., Lagus, H., Kankuri, E. M., & Jaks, V. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1073320 · Cited by 41
“The loss of TN-X has been associated with Ehlers-Danlos Syndrome, an autosomal dominant disorder of collagen deposition that is characterized by reduced skin tensile strength and reduced skin collagen content (Burch et al., 1997).”
BackgroundShichi, D., Kikkawa, E. F., Ôta, M., Katsuyama, Y., Kimura, A., Matsumori, A., Kulski, J. K., Naruse, T. K., & Inoko, H. (2005) · Tissue Antigens · doi:10.1111/j.1399-0039.2005.00457.x · Cited by 33
Dermal connective tissue development in mice: an essential role for tenascin-X
Egging, D. F., van Vlijmen, I., STARCHER, B. C., Gijssen, Y., Zweers, M. C., Blankevoort, L., Bristow, J., & Schalkwijk, J. (2005) · Cell and Tissue Research · doi:10.1007/s00441-005-0100-5 · Cited by 42
“We conclude that TNX knockout mice only partially recapitulate the phenotype of TNX-deficient EDS patients, and that TNX could potentially be involved in maturation and/or maintenance of the dermal collagen and elastin network.”
BackgroundInfluentialSelf-citationSpeiser, P. (2001) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200101020-00003 · Cited by 34
Rupert, K. L., Rennebohm, R. M., & Yu, C. Y. (1999) · Experimental and Clinical Immunogenetics · doi:10.1159/000019099 · Cited by 40
Hu, X., Zhang, Y., Zhang, A., Li, Y., Zhu, Z.-M., Shao, Z., Zeng, R., & Xu, L. X. (2009) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2009.0016 · Cited by 33
“Although the function of TNXB is still unknown, its deficiency in humans is associated with Ehlers-Danlos syndrome, a generalized connective tissue disorder resulting from altered metabolism of fibrillar collagens (Burch et al., 1997).”
Chen, W., Kim, M. S., Shanbhag, S., Arai, A., VanRyzin, C., McDonnell, N. B., & Merke, D. P. (2009) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33092 · Cited by 32
“…aortic valve has been reported in a 16-year-old boy with a clinical diagnosis of EDS Type II [Dotti et al., 1999] which would now be classified as the classic form of EDS [Beighton et al., 1998], and may be caused by a homozygous TNXB defect [Burch et al., 1997; Schalkwijk et al., 2001].”
BackgroundMethodInfluentialLethias, C., Elefteriou, F., Parsiegla, G., Exposito, J., & Garrone, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010210200 · Cited by 38
Kamatani, Y., Matsuda, K., Ohishi, T., Ohtsubo, S., Yamazaki, K., Iida, A., Hosono, N., Kubo, M., Yumura, W., Nitta, K., et al. (2008) · Journal of Human Genetics · doi:10.1007/s10038-007-0219-1 · Cited by 31
“Ehlers–Danlos-like syndrome (Burch et al. 1997), but the role of TNXB in the immune system was not known.”
BackgroundMatricellular Proteins: Functional Insights From Non-mammalian Animal Models
Adams, J. C. (2018) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2018.02.003 · Cited by 34
Revisiting the Tenascins: Exploitable as Cancer Targets?
Tucker, R. P., & Degen, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.908247 · Cited by 37
Meloty-Kapella, C. V., Degen, M., Chiquet‐Ehrismann, R., & Tucker, R. P. (2006) · Developmental Dynamics · doi:10.1002/dvdy.20731 · Cited by 31
“Tenascin-X knockout mice develop normally but eventually display connective tissue disorders similar to Ehlers-Danlos syndrome (Mao et al., 2002), which can also result from mutations of human tenascin-X (e.g., see Burch et al., 1997).”
BackgroundVesicoureteral reflux and the extracellular matrix connection
Tokhmafshan, F., Brophy, P. D., Gbadegesin, R. A., & Gupta, I. R. (2017) · Pediatric Nephrology · doi:10.1007/s00467-016-3386-5 · Cited by 30
Sakiyama, T., Kubo, A., Sasaki, T., Yamada, T., Yabe, N., Matsumoto, K., & Futei, Y. (2015) · The Journal of Dermatology · doi:10.1111/1346-8138.12829 · Cited by 30
Lao, Q., Brookner, B., & Merke, D. P. (2019) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2019.06.001 · Cited by 29
“*Carrier of a 30-Kb deletion. yCAH-X CH-1: CYP21A1P-TNXA/TNXB chimera with TNXB exons 35e44 replaced by TNXA. zCAH-X CH-2: CYP21A1P-TNXA/TNXB chimera with TNXB exons 40e44 replaced by TNXA.”
BackgroundInfluentialTNXB locus may be a candidate gene predisposing to schizophrenia
Wei, J., & Hemmings, G. P. (2004) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20093 · Cited by 29
“TNXB deficiency leads to an autosomal recessive form of the Ehlers–Danlos-like syndrome, which is a connective tissue disorder characterized by hyperextensible skin, hypermobile joints, and tissue fragility [Burch et al., 1997; Schalkwijk et al., 2001].”
BackgroundHistory of Adrenal Research: From Ancient Anatomy to Contemporary Molecular Biology
Miller, W. L., & White, P. C. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac019 · Cited by 35
Self-citationMild Muscular Features in Tenascin-X Knockout Mice, A Model of Ehlers–Danlos Syndrome
Voermans, N. C., Verrijp, K., Eshuis, L., Balemans, M. C. M., Egging, D., Sterrenburg, E., van Rooij, I. A. L. M., van der Laak, J. A. W. M., Schalkwijk, J., M van der Maarel, S., et al. (2011) · Connective Tissue Research · doi:10.3109/03008207.2010.551616 · Cited by 29
“TNX-deficient type EDS has a phenotype similar to the classic type EDS with hypermobile joints, hyperexten-sible skin, and easy bruising, but without atrophic scarring [1–3].”
MethodJaatinen, T., Ruuskanen, O., Truedsson, L., & Lokki, M. (1999) · Human Immunology · doi:10.1016/s0198-8859(99)00047-6 · Cited by 31
Lee, H.-H., Lee, Y.-J., Wang, Y.-M., Chao, H.-T., Niu, D.-M., Chao, M.-C., Tsai, F.-J., Lo, F.-S., & Lin, S.-J. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.10.008 · Cited by 28
Bruch’s membrane abnormalities in PRDM5-related brittle cornea syndrome
Porter, L. F., Gallego‐Pinazo, R., Keeling, C. L., Kamieniorz, M., Zoppi, N., Colombi, M., Giunta, C., Bonshek, R. E., Manson, F. D. C., & Black, G. C. M. (2015) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-015-0360-4 · Cited by 29
“Integrin α8 is the major tenascin receptor [19] and homozygous mutations in tenascin X cause a subtype of Ehlers-Danlos syndrome [20, 21].”
BackgroundRymen, D., Ritelli, M., Zoppi, N., Cinquina, V., Giunta, C., Rohrbach, M., & Colombi, M. (2019) · Genes · doi:10.3390/genes10110843 · Cited by 33
“Although a TNX null-phenotype was verified both on the protein and on the mRNA level, a mutation on the second allele could not be identified [8].”
BackgroundColman, M., Syx, D., Wandele, I. D., Dhooge, T., Symoens, S., & Malfait, F. (2021) · Human Mutation · doi:10.1002/humu.24258 · Cited by 30
“Biallelic pathogenic TNXB variants are associated with classical‐like EDS type 1 (clEDS1, MIM #606408), hitherto reported in 51 individuals, with clinical features resembling cEDS except for the absence of atrophic scarring (Burch et al., 1997; Green et al., 2020; Schalkwijk et al., 2001).”
BackgroundThe Adrenal Cortex and Its Disorders
Miller, W. L., Achermann, J. C., & Flück, C. E. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50017-x · Cited by 33
Self-citationBilateral Focal Polymicrogyria in Ehlers-Danlos Syndrome
Echaniz‐Laguna, A., Martin, A. D. S., Lafontaine, A. L., Tasch, E., Thomas, P., Hirsh, E., Marescaux, C., & Andermann, F. (2000) · Archives of Neurology · doi:10.1001/archneur.57.1.123 · Cited by 28
“Dermatological consultation confirmed a diagnosis of type III EDS.”
BackgroundInfluentialEgging, D. F., van Vlijmen-Willems, I., Choi, J., Peeters, A. C. T. M., van Rens, D., Veit, G., Koch, M., Davis, E. C., & Schalkwijk, J. (2008) · Cell and Tissue Research · doi:10.1007/s00441-008-0591-y · Cited by 27
“…Medicine Cologne, Medical Faculty, University of Cologne, Cologne, Germany J. Schalkwijk (*) P.O. Box 9101, 6500 HB Nijmegen, The Netherlands e-mail: j.schalkwijk@derma.umcn.nl abnormal (Burch et al. 1997; Schalkwijk et al. 2001; Zweers et al. 2003; Peeters et al. 2004; Lindor and Bristow 2005).”
A tenascin knockout with a phenotype
Erickson, H. (1997) · Nature Genetics · doi:10.1038/ng0997-5 · Cited by 26
Tenascin-X—Discovery and Early Research
Miller, W. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.612497 · Cited by 26
“Expression of TNXB is tissue-specific and developmentally regulated (33, 34).”
BackgroundSelf-citationGreen, C. E., Ghali, N., Akilapa, R., Angwin, C., Baker, D., Bartlett, M., Bowen, J. M., Brady, A. F., Brock, J., Chamberlain, E. D., et al. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-0850-1 · Cited by 32
“A monogenic type of EDS, previously called tenascin-X (TN-X) deficient EDS, was first reported in 1997.(3) It is caused by recessive pathogenic variants in TNXB resulting in deficiency of TN-X.”
BackgroundAssociation study between the TNXB locus and schizophrenia in a Japanese population
Tochigi, M., Zhang, X., Ohashi, J., Hibino, H., Otowa, T., Rogers, M., Kato, T., Okazaki, Y., Kato, N., Tokunaga, K., et al. (2007) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30441 · Cited by 25
“TNX deficiency causes an autosomal recessive form of Ehlers-Danlos syndrome, which is a connective tissue disorder characterized by hyperextensive skin, hypermobile joints, and tissue fragility [Burch et al., 1997; Schalkwijk et al., 2001].”
BackgroundTenascin-Y, a Component of Distinctive Connective Tissues, Supports Muscle Cell Growth
Hagios, C., Brown-Luedi, M., & Chiquet‐Ehrismann, R. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4658 · Cited by 29
Nanomechanical Properties of Tenascin-X Revealed by Single-Molecule Force Spectroscopy
Jollymore, A., Lethias, C., Peng, Q., Cao, Y., & Li, H. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.11.038 · Cited by 23
Multiple Roles of Tenascins in Homeostasis and Pathophysiology of Aorta
Imanaka‐Yoshida, K., & Matsumoto, K. (2018) · Annals of Vascular Diseases · doi:10.3400/avd.ra.17-00118 · Cited by 22
Walker, L. C., Overstreet, M. A., Willing, M. C., Marini, J. C., Cabral, W. A., Pals, G., Bristow, J. D., Atsawasuwan, P., Yamauchi, M., & Yeowell, H. N. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30302 · Cited by 23
“Tenascin-X Is Normal in EDS VIB Levels of tenascin-X were measured by Western blot analysis of cultured dermal fibroblasts [Burch et al., 1997] from the four EDS VIB patients, a normal individual (CON), and from a tenascin-X-deficient patient (NEG) (Fig.”
MethodInfluentialSelf-citationBehavioral Alterations in Mice Lacking the Gene for Tenascin-X
Kawakami, K., & Matsumoto, K.-I. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.590 · Cited by 22
Hashimoto, K., Kajitani, N., Miyamoto, Y., & Matsumoto, K. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.12.025 · Cited by 26
Serum Tenascin-X Strongly Binds to Vascular Endothelial Growth Factor
Ishitsuka, T., Ikuta, T., Ariga, H., & Matsumoto, K. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1004 · Cited by 22
Lai, A. C., Wallner, K., Cao, J., Chen, L. S., Karagueuzian, H. S., EISHBEIN, M. C., Chen, P., & Sharifi, B. G. (2000) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2000.01345.x · Cited by 24
(2004) · PubMed · Cited by 22
Biomarkers for Ehlers-Danlos Syndromes: There Is a Role?
Caliogna, L., Guerrieri, V., Annunziata, S., Bina, V., Brancato, A. M., Castelli, A., Jannelli, E., Ivone, A., Grassi, F. A., Mosconi, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810149 · Cited by 24
“Tnxb deletion can even be caused by a contiguous deletion syndrome (CAH-X) [60], in which patients have a 21-hydroxylase deficiency causing congenital adrenal hyperplasia and hEDS in which tnxb exons are replaced by tnxa, giving birth to tnxa/tnxb chimeras [60–62].”
BackgroundMorissette, R., Merke, D. P., & McDonnell, N. B. (2014) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2013.12.004 · Cited by 21
“Although TNX deficiency was first associated with EDS over a decade ago,[5] little is known about how impairment of this ECM protein results in an EDS phenotype beyond its regulation of collagen deposition and crosslinking.”
BackgroundInfluentialYang, M., & White, P. C. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae535 · Cited by 20
“Homozygosity for such a chimera leads to a contiguous gene syndrome consisting of CAH and Ehlers-Danlos syndrome (94), which is rarely clinically reported in patients with severe CAH.”
Congenital Adrenal Hyperplasia and Ehlers-Danlos Syndrome
Marino, R. M., Moresco, A., Garrido, N. P., Ramírez, P., & Belgorosky, A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.803226 · Cited by 23
“The first report of TNX deficiency was a description of a patient with CAH and EDS (15).”
BackgroundInfluential
Metadata
- Authors
- Burch, G. H., Gong, Y., Liu, W., Dettman, R. W., Curry, C. J., Smith, L., Miller, W. L., & Bristow, J.
- Affiliations
- University of California, San Francisco (US)
- Children's Hospital Central California (US)
- University of Washington (US)
- Corresponding author
- Bristow, James
- Venue
- Nature Genetics
- Published
- 1997-09
- Volume
- 17
- Issue
- 1
- Pages
- 104-108
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1989696897
- Semantic Scholar
- 875064e9bae6e7e062e9583a6639eb0ce870bd3b
- Cited by
- 366
- References
- 31
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 8 · 2023: 7 · 2022: 12 · 2021: 17 · 2020: 13 · 2019: 10 · 2018: 11 · 2017: 10 · 2016: 10 · 2015: 15 · 2014: 10 · 2013: 17 · 2012: 13
- FWCI
- 6.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k08hl002695-02)
- National Heart, Lung, and Blood Institute (HL 02695)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-37922, R01DK037922)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Skin and Cellular Biology Research
- Keywords
- tenascin-X, Ehlers-Danlos syndrome, contiguous gene syndrome, 21-hydroxylase deficiency, connective tissue diseases, skin hyperextensibility, vascular fragility, delayed wound healing, recessive inheritance, extracellular matrix proteins, dermal fibroblasts
- MeSH terms
- Adult, Alleles, Biopsy, Cells, Cultured, Ehlers-Danlos Syndrome, Female, Fibroblasts, Humans, Male, Pedigree, Skin, Polymerase Chain Reaction, Sequence Deletion, Tenascin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.